Metraipolis › archive › dc_97239f137360
Rethinking PDAC: from immunological silence to therapeutic opportunity — Europe PMC PMID:42643613
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/42643613
- DOI
- 10.3389/fimmu.2026.1909191
- License (as archived)
- solo-consultazione
- Archived
- 2026-10-16T21:43:02.013Z
- SHA-256 of the archived text
8908f1c2e34033ff62ad2fc8d20638242513bde389240674f110e8ff37baac34- Stable URL of this page
https://metraipolis.com/documento/dc_97239f137360
How to cite
Rethinking PDAC: from immunological silence to therapeutic opportunity — Europe PMC PMID:42643613 — Europe PMC (en), https://europepmc.org/article/MED/42643613 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_97239f137360 (Metraipolis archive dc_97239f137360, sha256 8908f1c2e34033ff62ad2fc8d20638242513bde389240674f110e8ff37baac34)
BibTeX
@misc{dc97239f137360,
title = {Rethinking PDAC: from immunological silence to therapeutic opportunity — Europe PMC PMID:42643613},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/42643613},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_97239f137360; sha256 8908f1c2e34033ff62ad2fc8d20638242513bde389240674f110e8ff37baac34},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42643613. Agents can read the archived copy with the MCP tool read_document.